Skip to content

Drug interactions

Olaparib + Ticagrelor

Severity: Minor

Olaparib and Ticagrelor: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Olaparib is metabolized by CYP3A4, and ticagrelor is a weak CYP3A inhibitor that may modestly raise olaparib levels. This could increase hematologic toxicity such as anemia and thrombocytopenia, which also matters for bleeding risk on ticagrelor.

What this interaction means in plain words

Olaparib and Ticagrelor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Olaparib belongs to Oncology; Ticagrelor belongs to Cardiovascular.

Evidence level: Low

Why it happens

Weak CYP3A4 inhibition by ticagrelor may slightly reduce olaparib clearance.

What to do

Monitor blood counts and for bleeding. No empirical olaparib dose reduction is generally needed for a weak inhibitor.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Olaparib and Ticagrelor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Olaparib with Ticagrelor?

MediHelp rates the interaction as minor. Olaparib and Ticagrelor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Olaparib is metabolized by CYP3A4, and ticagrelor is a weak CYP3A inhibitor that may modestly raise olaparib levels. This could increase hematologic toxicity such as anemia and thrombocytopenia, which also matters for bleeding risk on ticagrelor.

How serious is the interaction between Olaparib and Ticagrelor?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and for bleeding. No empirical olaparib dose reduction is generally needed for a weak inhibitor.

What other medicines interact with Ticagrelor?

MediHelp also lists interactions of Ticagrelor with, for example, Itraconazole, Ketoconazole, Levoketoconazole. The full list is on the Ticagrelor page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in